PlainRecalls
FDA Drug Moderate Class II Terminated

Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactured for: Ferring Pharmaceuticals Inc., Parsippany, NJ NDC# 55566-6500-03

Reported: July 5, 2023 Initiated: June 12, 2023 #D-0879-2023

Product Description

Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactured for: Ferring Pharmaceuticals Inc., Parsippany, NJ NDC# 55566-6500-03

Reason for Recall

cGMP deviations: potential for Microbial Contamination of Non-Sterile Products

Details

Units Affected
N/A
Distribution
USA Nationwide
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactured for: Ferring Pharmaceuticals Inc., Parsippany, NJ NDC# 55566-6500-03. Recalled by Ferring Pharmaceuticals Inc. Units affected: N/A.
Why was this product recalled?
cGMP deviations: potential for Microbial Contamination of Non-Sterile Products
Which agency issued this recall?
This recall was issued by the FDA Drug on July 5, 2023. Severity: Moderate. Recall number: D-0879-2023.